Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 72

    Aurobindo Pharma rises 5 pc post clarification on USFDA observations for Unit-7

    Aurobindo Pharma rises 5 pc post clarification on USFDA observations for Unit-7

    Medical Dialogues Bureau10 Oct 2019 11:56 AM IST
    A clarification was sought from Aurobindo Pharma regarding declining share prices on the back of USFDA observations.New Delhi: Shares of Aurobindo...
    Torrent Pharma Indrad facility gets USFDA warning letter

    Torrent Pharma Indrad facility gets USFDA warning letter

    Medical Dialogues Bureau10 Oct 2019 11:44 AM IST
    This action by the United States Food and Drug Administration (USFDA) follows earlier intimation received from the regulator in August 2019, wherein...
    Zydus Cadila gets USFDA nod for Colesevelam Hydrochloride tablets for lowering cholesterol

    Zydus Cadila gets USFDA nod for Colesevelam Hydrochloride tablets for lowering cholesterol

    Medical Dialogues Bureau10 Oct 2019 11:34 AM IST
    Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Colesevelam Hydrochloride tablets,...
    Lupin Mandideep facility gets GMP certificate from Japanese agency PMDA

    Lupin Mandideep facility gets GMP certificate from Japanese agency PMDA

    Farhat Nasim10 Oct 2019 9:45 AM IST
    Pharmaceutical and Medical Devices Agency (PMDA) inspection closed with no critical or major observations. The GMP Certificate issued by the Japanese...
    Galderma wins USFDA nod for AKLIEF Cream to treat acne

    Galderma wins USFDA nod for AKLIEF Cream to treat acne

    Medical Dialogues Bureau10 Oct 2019 9:30 AM IST
    New Delhi: Galderma, announced recently that the U.S. Food and Drug Administration (USFDA) has approved AKLIEF (trifarotene) Cream, 0.005% for the...
    Glenmark gets tentative USFDA nod for generic version of Tecfidera Capsules

    Glenmark gets tentative USFDA nod for generic version of Tecfidera Capsules

    Medical Dialogues Bureau9 Oct 2019 12:19 PM IST
    "According to IQVIATM sales data for the 12 month period ending August 2019, the Tecfidera Capsules, 120 mg and 240 mg market2 achieved annual sales...
    Bliss GVS Pharma arm clears USFDA inspection of Ambernath facility

    Bliss GVS Pharma arm clears USFDA inspection of Ambernath facility

    Medical Dialogues Bureau9 Oct 2019 9:45 AM IST
    "The successful audit outcome from USFDA is a reflection of the steady progress that we are making into the mature pharma markets," Bliss GVS Pharma...
    Fight against Rabies: India hands over 10k vials of anti-rabies vaccines to Myanmar

    Fight against Rabies: India hands over 10k vials of anti-rabies vaccines to Myanmar

    Medical Dialogues Bureau9 Oct 2019 9:35 AM IST
    In a handing over ceremony held in Yangon on Tuesday, the Deputy Chief of Mission Sumit Seth handed over the vials of Anti-Rabies Vaccines to...
    Amid cancer scare GSK recalls heartburn drug Zantac as precautionary measure

    Amid cancer scare GSK recalls heartburn drug Zantac as precautionary measure

    Medical Dialogues Bureau9 Oct 2019 9:30 AM IST
    GSK is recalling all unexpired stock of Zantac from pharmacies due to possible contamination with an impurity N-nitrosodimethylamine (NDMA), the...
    Glenmark shares fall 9pc on USFDA warning letter for Baddi facility

    Glenmark shares fall 9pc on USFDA warning letter for Baddi facility

    Medical Dialogues Bureau8 Oct 2019 3:08 PM IST
    Drug firm Glenmark Pharmaceuticals on Saturday said it has received a warning letter from the United States Food and Drug Administration (USFDA) for...
    Aurobindo Pharma Unit-7 gets 7 USFDA observations

    Aurobindo Pharma Unit-7 gets 7 USFDA observations

    Medical Dialogues Bureau8 Oct 2019 2:54 PM IST
    The United States Food and Drug Administration (USFDA) conducted a Current Good Manufacturing Practices (CGMP) inspection at the company's unit-7...
    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Medical Dialogues Bureau8 Oct 2019 9:50 AM IST
    "We are planning an investment of around Rs 50 crore for setting up an advanced cancer care unit, an additional cath lab as well as an IVF unit in the...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok